A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.

<h4>Background</h4>Insurance coverage of tobacco cessation medications increases their use and reduces smoking prevalence in a population. However, uncertainty about the impact of this coverage on health care utilization and costs is a barrier to the broader adoption of this policy, espe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thomas Land, Nancy A Rigotti, Douglas E Levy, Mark Paskowsky, Donna Warner, Jo-Ann Kwass, Leann Wetherell, Lois Keithly
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2010
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/7a79bed4ad6a46e59b50ab570c19ce12
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7a79bed4ad6a46e59b50ab570c19ce12
record_format	dspace
spelling	oai:doaj.org-article:7a79bed4ad6a46e59b50ab570c19ce122021-11-18T05:41:59ZA longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.1549-12771549-167610.1371/journal.pmed.1000375https://doaj.org/article/7a79bed4ad6a46e59b50ab570c19ce122010-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21170313/pdf/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Insurance coverage of tobacco cessation medications increases their use and reduces smoking prevalence in a population. However, uncertainty about the impact of this coverage on health care utilization and costs is a barrier to the broader adoption of this policy, especially by publicly funded state Medicaid insurance programs. Whether a publicly funded tobacco cessation benefit leads to decreased medical claims for tobacco-related diseases has not been studied. We examined the experience of Massachusetts, whose Medicaid program adopted comprehensive coverage of tobacco cessation medications in July 2006. Over 75,000 Medicaid subscribers used the benefit in the first 2.5 years. On the basis of earlier secondary survey work, it was estimated that smoking prevalence declined among subscribers by 10% during this period.<h4>Methods and findings</h4>Using claims data, we compared the probability of hospitalization prior to use of the tobacco cessation pharmacotherapy benefit with the probability of hospitalization after benefit use among Massachusetts Medicaid beneficiaries, adjusting for demographics, comorbidities, seasonality, influenza cases, and the implementation of the statewide smoke-free air law using generalized estimating equations. Statistically significant annualized declines of 46% (95% confidence interval 2%-70%) and 49% (95% confidence interval 6%-72%) were observed in hospital admissions for acute myocardial infarction and other acute coronary heart disease diagnoses, respectively. There were no significant decreases in hospitalizations rates for respiratory diagnoses or seven other diagnostic groups evaluated.<h4>Conclusions</h4>Among Massachusetts Medicaid subscribers, use of a comprehensive tobacco cessation pharmacotherapy benefit was associated with a significant decrease in claims for hospitalizations for acute myocardial infarction and acute coronary heart disease, but no significant change in hospital claims for other diagnoses. For low-income smokers, removing the barriers to the use of smoking cessation pharmacotherapy has the potential to decrease short-term utilization of hospital services.Thomas LandNancy A RigottiDouglas E LevyMark PaskowskyDonna WarnerJo-Ann KwassLeann WetherellLois KeithlyPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 7, Iss 12, p e1000375 (2010)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Thomas Land Nancy A Rigotti Douglas E Levy Mark Paskowsky Donna Warner Jo-Ann Kwass Leann Wetherell Lois Keithly A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
description	<h4>Background</h4>Insurance coverage of tobacco cessation medications increases their use and reduces smoking prevalence in a population. However, uncertainty about the impact of this coverage on health care utilization and costs is a barrier to the broader adoption of this policy, especially by publicly funded state Medicaid insurance programs. Whether a publicly funded tobacco cessation benefit leads to decreased medical claims for tobacco-related diseases has not been studied. We examined the experience of Massachusetts, whose Medicaid program adopted comprehensive coverage of tobacco cessation medications in July 2006. Over 75,000 Medicaid subscribers used the benefit in the first 2.5 years. On the basis of earlier secondary survey work, it was estimated that smoking prevalence declined among subscribers by 10% during this period.<h4>Methods and findings</h4>Using claims data, we compared the probability of hospitalization prior to use of the tobacco cessation pharmacotherapy benefit with the probability of hospitalization after benefit use among Massachusetts Medicaid beneficiaries, adjusting for demographics, comorbidities, seasonality, influenza cases, and the implementation of the statewide smoke-free air law using generalized estimating equations. Statistically significant annualized declines of 46% (95% confidence interval 2%-70%) and 49% (95% confidence interval 6%-72%) were observed in hospital admissions for acute myocardial infarction and other acute coronary heart disease diagnoses, respectively. There were no significant decreases in hospitalizations rates for respiratory diagnoses or seven other diagnostic groups evaluated.<h4>Conclusions</h4>Among Massachusetts Medicaid subscribers, use of a comprehensive tobacco cessation pharmacotherapy benefit was associated with a significant decrease in claims for hospitalizations for acute myocardial infarction and acute coronary heart disease, but no significant change in hospital claims for other diagnoses. For low-income smokers, removing the barriers to the use of smoking cessation pharmacotherapy has the potential to decrease short-term utilization of hospital services.
format	article
author	Thomas Land Nancy A Rigotti Douglas E Levy Mark Paskowsky Donna Warner Jo-Ann Kwass Leann Wetherell Lois Keithly
author_facet	Thomas Land Nancy A Rigotti Douglas E Levy Mark Paskowsky Donna Warner Jo-Ann Kwass Leann Wetherell Lois Keithly
author_sort	Thomas Land
title	A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
title_short	A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
title_full	A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
title_fullStr	A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
title_full_unstemmed	A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
title_sort	longitudinal study of medicaid coverage for tobacco dependence treatments in massachusetts and associated decreases in hospitalizations for cardiovascular disease.
publisher	Public Library of Science (PLoS)
publishDate	2010
url	https://doaj.org/article/7a79bed4ad6a46e59b50ab570c19ce12
work_keys_str_mv	AT thomasland alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT nancyarigotti alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT douglaselevy alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT markpaskowsky alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT donnawarner alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT joannkwass alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT leannwetherell alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT loiskeithly alongitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT thomasland longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT nancyarigotti longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT douglaselevy longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT markpaskowsky longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT donnawarner longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT joannkwass longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT leannwetherell longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease AT loiskeithly longitudinalstudyofmedicaidcoveragefortobaccodependencetreatmentsinmassachusettsandassociateddecreasesinhospitalizationsforcardiovasculardisease
_version_	1718424857638600704

A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.

Ejemplares similares